2012 CURE Challenge Award
| Challenge Award |
 |
Submission
Guidelines |
 |
CURE promotes research that advances the search for a cure, and addresses the goal of “no seizures, no side effects.” Successful applicants for the Challenge Award should propose research in at least one of the following priority areas: (1) the basic mechanisms of epileptogenesis; (2) the multifaceted causes of epilepsy; (3) the pediatric epilepsy syndromes; (4) new animal models of epilepsy. We specifically encourage studies that may not be currently fundable by other agencies, such as the NIH, because of their preliminary or unconventional nature.
Eligibility: This award will be presented to an established investigator* exploring cutting-edge approaches to curing epilepsy. Preference will be given to research addressing the more severe and refractory syndromes of epilepsy. International applicants are welcome. Researchers who serve on CURE’s Scientific Advisory Board are ineligible to apply for or sponsor a grant for the duration of their term. All materials must be submitted in English.
*Established investigators are university faculty at the associate professor level or above. Generally, early career investigators are university faculty at the assistant professor level (or hold an equivalent position in a non-university research organization).
Amount: Requests may be made for up to $250,000 for two or three years (for a maximum of $250,000 total).
2012 FUNDING CYCLE
Deadline for Receipt of LOI: December 13, 2011
Notification of Invitation to Apply: early-February 2012
Deadline for Receipt of Full Application: April 3, 2012
Award Announcement: July 2012
Earliest Project Start Date: September 1, 2012 |
Letter of Intent: All applicants must submit a Letter of Intent. All LOIs are reviewed by CURE’s Scientific Advisory Board and Research Review Board, with the final decisions as to who will be invited to submit formal proposals made by the CURE Board of Directors.
For questions, please contact Danielle Davis at the CURE office, 312.255-1801, or email danielle.davis@CUREepilepsy.org.
|
